Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: How do we mention S&L Warrant conversion issue in the letter? SGE

SGE - the point I was trying to make was that we should be mindful not to embarass ourselves by making claims about S&L selling massive amounts of shares if in fact it's actually not true.  We're all "pretty sure" it's true but you never know with this stock.  Remember, Pohl stated that he is "perplexed" as to why the SP acts the way it does.  If S&L is doing what we think they're doing, he certainly shouldn't be perplexed at all and should not have made that statement. 

However, I do think Ron is more than capable of describing/mentioning this issue based on what information/facts we do have.

I think the 10Q will at least give us a better idea as to what S&L has been doing.  We should be able to see "some" converting and selling by S&L on the next 10Q (if in fact they have been converting and selling).

I like your idea about having S&L agree to hold off on selling until after the SP hits $5, $10.  - Brilliant! 


Apr 19, 2007 10:03AM

Apr 19, 2007 10:59AM

Apr 19, 2007 11:10AM

Apr 19, 2007 11:15AM

Apr 19, 2007 11:19AM

Apr 19, 2007 11:27AM

Apr 19, 2007 11:33AM

Apr 19, 2007 11:35AM

Apr 19, 2007 11:54AM

Apr 19, 2007 11:55AM

Apr 19, 2007 11:56AM

Apr 19, 2007 11:59AM

Apr 19, 2007 12:06PM

Apr 19, 2007 01:22PM
Share
New Message
Please login to post a reply